Dana Investment Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
N
TCM
APM
AAP
Dana Investment Advisors's ALT Position: Q3 2023 in Review
Dana Investment Advisors sold out of Altimmune (ALT) in Q3 2023, closing a stake of 58,740 shares — an estimated $207K sold.
Dana Investment Advisors first reported a position in ALT in Q2 2021 and held it in 4 quarters. The position peaked at $243K in Q1 2023. 112 funds tracked by Wall St. Rank hold ALT as of Q3 2023.
- Dana Investment Advisors reported no remaining Altimmune position as of Q3 2023 after selling out during the quarter.
- Dana Investment Advisors sold 58,740 Altimmune shares in Q3 2023, an estimated $207K.
- Dana Investment Advisors first reported a position in Altimmune in Q2 2021 and held it in 4 quarters.
- Dana Investment Advisors's Altimmune position peaked at $243K in Q1 2023.
- 112 funds tracked by Wall St. Rank held Altimmune as of Q3 2023.
Based on Dana Investment Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.